US5545130A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Flow through electroporation method
Assignee: Genetronics Inc
•
Filing: 1994-10-12
•
Granted: 1996-08-13
•
Expires: 2014-10-12
Abstract
Abstract A flow through apparatus for implanting molecules into living blood cells of a patient, comprises a housing including an elongated flow through chamber having an inlet and an outlet at opposite ends thereof, a pair of elongated spaced apart parallel electrodes disposed between the inlet and the outlet for fluid to flow therebetween, a continuous flow shunt including a pump for withdrawing blood from a patient, passing it through the flow through chamber between the electrodes and returning it to the patient, apparatus for injecting a predetermined quantity of fluid medium carrying preselected molecules into the blood after it has been drawn from the patient and before it passes through said chamber, and an electrical source for applying a predetermined electric signal of a predetermined amplitude and duration to the electrodes for generating and repeatedly applying electric fields of a predetermined amplitude and duration to the flow of the mixture of blood and fluid medium in order to make the walls of preselected cells in the blood transiently permeable to permit molecules to enter the preselected cells without killing the cells.
Inventors
- 👤 Gunter A. Hofmann
- 👤 Henry R. Kent
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 09:49
CPC Classifications
A; A61; A61M; A61M1/00; A61M1/36; A61K; A61K35/00; A61K35/12; A61K35/14; A61K35/18; A61K48/00; C; C12; C12M; C12M35/00; C12M35/02; C12N; C12N15/00; C12N15/09; C12N15/87
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
186 words
A continuous flow process for implanting molecules into living blood cells of a patient, comprising the steps of: providing an elongated flow through chamber having an inlet and an outlet at opposite ends thereof and a pair of elongated spaced apart parallel electrodes disposed between the inlet and the outlet for fluid to flow between; selecting and connecting continuous flow shunt means to a patient; withdrawing a continuous stream of blood from the patient; passing the blood through said flow through chamber between said electrodes and returning it to the patient; injecting a predetermined quantity of fluid medium carrying preselected molecules into the blood after it has been drawn from the patient and before it passes through said chamber; and applying a predetermined electric signal of a predetermined amplitude and duration to said electrodes for generating and repeatedly applying electric fields of a predetermined amplitude and duration to the flow of the mixture of blood and fluid medium in order to make the walls of preselected cells in the blood transiently permeable to permit said preselected molecules to enter said preselected cells without killing said cells.
Claim 2
Dependent Claim
186 words
A continuous flow process for implanting molecules into living blood cells of a patient, comprising the steps of: providing an elongated flow through chamber having an inlet and an outlet at opposite ends thereof and a pair of elongated spaced apart parallel electrodes disposed between the inlet and the outlet for fluid to flow between; selecting and connecting continuous flow shunt means to a patient; withdrawing a continuous stream of blood from the patient; passing the blood through said flow through chamber between said electrodes and returning it to the patient; injecting a predetermined quantity of fluid medium carrying preselected molecules into the blood after it has been drawn from the patient and before it passes through said chamber; and applying a predetermined electric signal of a predetermined amplitude and duration to said electrodes for generating and repeatedly applying electric fields of a predetermined amplitude and duration to the flow of the mixture of blood and fluid medium in order to make the walls of preselected cells in the blood transiently permeable to permit said preselected molecules to enter said preselected cells without killing said cells.
Claim 3
Dependent Claim
22 words
A method according to claim 1 wherein the said preselected macromolecules are selected from the group consisting of genes and pharmaceutical compounds.
Claim 4
Dependent Claim
29 words
A method according to claim 1 and further comprising the step of actively pumping the blood outside the patient from a first catheter and back through a second catheter.
Claim 5
Dependent Claim
22 words
A method according to claim 1 wherein the preselected cells are selected from the group consisting of red and white blood cells.
Claim 6
Dependent Claim
39 words
A method according to claim 1 wherein the electric fields are applied to the mixture of blood and medium in said flow through chamber having a pair of spaced apart electrodes to which a predetermined electric signal is applied.
Claim 7
Dependent Claim
38 words
A method according to claim 5 wherein the electric signal has a wave form selected from the group consisting of an exponentially decaying pulse, a square pulse, a unipolar oscillating pulse train and a bipolar oscillating pulse train.
Claim 8
Dependent Claim
21 words
A method according to claim 6 wherein each pulse has a duration of between approximately ten microseconds and one hundred milliseconds.
Claim 9
Dependent Claim
29 words
A method according to claim 7 wherein there are between approximately one pulse and one hundred pulses per liquid volume element as it passes through the flow through chamber.
Claim 10
Dependent Claim
21 words
A method according to claim 1 wherein the electric field has a strength of between approximately 0.2 kV/cm and 20.0 kV/cm.
Claim 11
Dependent Claim
45 words
A method according to claim 5 wherein the preselected cells are lymphocytes, the electric field has a strength of approximately 0.55 kV/cm and the electric signal has a pulse train wave form that decays exponentially with a pulse duration of approximately fifty to fifty-five milliseconds.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-08-13 | 2000-02-12 | 2000-08-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-08-13 | 2004-02-12 | 2004-08-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-08-13 | 2008-02-12 | 2008-08-13 | $7700.00 | Window Closed / Lapsed |